• Exosomal SNORD52 Drives M2 Macrophage Polarization via JAK2/

  2026-07-09

  This study reveals that exosomal SNORD52, derived from hepatoma cells, induces M2 macrophage polarization by activating the JAK2/STAT6 pathway—a mechanism linked to tumor-promoting immune modulation in hepatocellular carcinoma. These findings provide mechanistic insights into the tumor microenvironment and offer new experimental avenues for dissecting macrophage polarization in cancer research.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Guide

  2026-07-09

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody is designed for sensitive detection of rabbit IgG in immunoassays such as immunofluorescence, IHC, and flow cytometry. It is best suited for workflows requiring signal amplification and high specificity, but should not be used in diagnostic or clinical settings due to its research-only designation.

• LY294002: Advanced Dissection of PI3K Signaling in Neurobiol

  2026-07-08

  Discover how LY294002, a potent PI3K/Akt/mTOR signaling pathway inhibitor, uniquely enables mechanistic investigation of neuroplasticity and synaptic signaling beyond oncology. Explore its scientific applications, protocol guidance, and nuanced insights into behavioral neuroscience.

• Docosahexaenoic Acid (DHA): Applied Workflows for Neuroprote

  2026-07-08

  Docosahexaenoic Acid (DHA) is transforming neuroprotection research by targeting hippocampal lipid metabolism and cognitive resilience. This guide distills spatial metabolomics breakthroughs into concrete experimental protocols, with troubleshooting insights tailored for high-impact bench workflows.

• P2Y2 Receptor Activation Promotes Microglial Aβ Clearance in

  2026-07-07

  This study reveals that nucleotides released from amyloid β-treated microglia stimulate migration and β-amyloid uptake through P2Y2 receptor activation. These findings highlight a potential therapeutic axis for enhancing amyloid clearance in Alzheimer’s disease.

• Mapping Astrocyte Diversity: A Cross-Species Transcriptomic

  2026-07-07

  Schroeder et al. present a comprehensive transcriptomic atlas detailing astrocyte heterogeneity across brain regions and developmental stages in mouse and marmoset. Their integrative approach reveals both conserved and divergent molecular signatures, providing a foundation for understanding astrocyte specialization in health and disease.

• 3-Deazaadenosine Hydrochloride: Precision SAHH Inhibitor in

  2026-07-06

  3-Deazaadenosine hydrochloride empowers highly selective, reproducible interrogation of methylation-dependent pathways in hepatic stellate cell activation and fibrosis research. Leveraging APExBIO’s high-purity reagent, researchers can streamline assay workflows, troubleshoot methyltransferase modulation, and advance m6A pathway studies with confidence.

• Honokiol as a Precision Tool for Immunometabolic Assays

  2026-07-06

  Discover how Honokiol enables advanced immunometabolic research through selective NF-κB pathway inhibition and ROS scavenging. This article uniquely maps Honokiol's interface with T-cell metabolic regulation, offering practical assay guidance beyond existing protocols.

• Amikacin Sulfate: Precision Workflows for Mycobacterial Rese

  2026-07-05

  Harness the potent, targeted bactericidal activity of Amikacin Sulfate to streamline intracellular pathogen studies and maximize therapeutic efficacy in challenging infection models. This guide demystifies optimized protocols, advanced applications, and troubleshooting strategies to empower translational researchers using APExBIO’s trusted reagent.

• Ibrexafungerp Retains Potent Antifungal Activity at Vaginal

  2026-07-04

  The referenced study demonstrates that ibrexafungerp (MK 3118) maintains robust antifungal activity against both fluconazole-susceptible and -resistant vaginal Candida isolates at acidic pH. These results highlight the compound’s translational relevance for treating vulvovaginal candidiasis (VVC), particularly in cases where standard azoles lose efficacy.

• H-89: Precision cAMP-Dependent Protein Kinase Inhibitor in O

  2026-07-03

  H-89, a selective cAMP-dependent protein kinase inhibitor, is redefining how researchers dissect metabolic and signaling networks in bone formation. By enabling rigorous modulation of the cAMP-PKA pathway, H-89 from APExBIO empowers novel workflow enhancements in osteoblastogenesis, O-GlcNAcylation, and advanced metabolic assays.

• PSPro: Single-Cell-Type Spatial Proteome Profiling in Tissue

  2026-07-03

  Mao et al. introduce PSPro, an antibody-guided proximity labeling method enabling all-at-once spatial proteome profiling of complex tissues with single-cell-type resolution. This approach achieves high selectivity and proteome coverage, revealing spatial heterogeneity among cell subsets in tumor and spleen slices, with practical implications for advancing tissue microenvironment studies.

• Recombinant Annexin V Expression Advances Apoptosis Detectio

  2026-07-02

  This study details the robust bacterial production and purification of recombinant annexin V for sensitive detection of membrane alterations in apoptotic cells. The streamlined methodology improves assay specificity, supporting apoptosis research and offering broader implications for membrane biology experiments.

• Tacrine Hydrochloride Hydrate: Catalyzing Translational AD R

  2026-07-02

  This thought-leadership article examines Tacrine hydrochloride hydrate (Tetrahydroaminacrine) as a mechanistic and strategic cornerstone in Alzheimer's disease research. It blends foundational insights into acetylcholinesterase inhibition, neuroprotective mechanisms, and translational workflow optimization, while benchmarking APExBIO's formulation as a standard for reproducibility and innovation. Drawing on recent literature and competitive landscape analysis, the article positions Tacrine-based scaffolds at the forefront of multi-target drug design and offers a forward-looking perspective on their evolving clinical relevance.

• EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Reporter Efficien

  2026-07-01

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) is a 5-moUTP modified mRNA that enables robust, low-immunogenicity bioluminescent assays. This product combines Cap1 capping and poly(A) tail optimization to improve translation and transcript stability, making it a benchmark tool for gene expression and mRNA delivery studies.

16536 records 1/1103 page Next 12345 下5页 Last page